| Current advances in drug discovery for Chagas disease CB Scarim, DH Jornada, RC Chelucci, L de Almeida, JL Dos Santos, ... European journal of medicinal chemistry 155, 824-838, 2018 | 105 | 2018 |
| Promising nanotherapy in treating leishmaniasis A de Souza, DSS Marins, SL Mathias, LM Monteiro, MN Yukuyama, ... International Journal of Pharmaceutics 547 (1-2), 421-431, 2018 | 82 | 2018 |
| Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria CB Scarim, DH Jornada, MGM Machado, CMR Ferreira, JL Dos Santos, ... European journal of medicinal chemistry 162, 378-395, 2019 | 69 | 2019 |
| Recent advances in drug discovery against Mycobacterium tuberculosis: Metal-based complexes CB Scarim, RL de Farias, AV de Godoy Netto, CM Chin, JL Dos Santos, ... European Journal of Medicinal Chemistry 214, 113166, 2021 | 36 | 2021 |
| Thiazole, triazole, thio-and semicarbazone derivatives-Promising moieties for drug development for the treatment of tuberculosis CB Scarim, FR Pavan European Journal of Medicinal Chemistry Reports 1, 100002, 2021 | 21 | 2021 |
| Nitroheterocyclic derivatives: privileged scaffold for drug development against Chagas disease C Benito Scarim, C Man Chin Medicinal Chemistry Research 28 (12), 2099-2108, 2019 | 17 | 2019 |
| Hydroxymethylnitrofurazone treatment in indeterminate form of chronic Chagas disease: Reduced intensity of tissue parasitism and inflammation—A histopathological study CB Scarim, CR de Andrade, JA da Rosa, JL Dos Santos, CM Chin International Journal of Experimental Pathology 99 (5), 236-248, 2018 | 15 | 2018 |
| In vitro and in silico assessment of antitumor properties and biomolecular binding studies for two new complexes based on NiII bearing k2N, S-donor ligands RL Farias, AMR Polez, DES Silva, RD Zanetti, MB Moreira, VS Batista, ... Materials Science and Engineering: C 121, 111815, 2021 | 14 | 2021 |
| Oxazolidinones as versatile scaffolds in medicinal chemistry GFS Fernandes, CB Scarim, SH Kim, J Wu, D Castagnolo RSC Medicinal Chemistry 14 (5), 823-847, 2023 | 10 | 2023 |
| The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp CB Scarim, RC Chelucci, JL Dos Santos, CM Chin Medicinal Chemistry 16 (1), 24-38, 2020 | 10 | 2020 |
| Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review CB Scarim, AR Ribeiro, JA Rosa, CM Chin Revista da Sociedade Brasileira de Medicina Tropical 51, 133-140, 2018 | 10 | 2018 |
| Resveratrol and curcumin for Chagas disease treatment—a systematic review CHL Imperador, CB Scarim, PL Bosquesi, JR Lopes, A Cardinalli Neto, ... Pharmaceuticals 15 (5), 609, 2022 | 9 | 2022 |
| Current approaches to drug discovery for Chagas disease: methodological advances CB Scarim, CM Chin Combinatorial Chemistry & High Throughput Screening 22 (8), 509-520, 2019 | 9 | 2019 |
| Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against Trypanosoma cruzi CB Scarim, F Olmo, EI Ferreira, CM Chin, JM Kelly, AF Francisco International Journal of Molecular Sciences 22 (13), 6930, 2021 | 7 | 2021 |
| Synthesis and anti-inflammatory intestinal activity of new glucocorticoid derivatives MGM Machado, CB Scarim, CR de Andrade, JL dos Santos, CM Chin Medicinal Chemistry Research 29, 206-216, 2020 | 7 | 2020 |
| The Effect of Taurine on Hepatic Disorders [Version 1, 2 Approved with Reservation] P Rodella, LF Takase, JLD Santos, CB Scarim, EDO Vizioli, CM Chin Curr Updates Hepatol Gastroenterol 1, 1.1, 2017 | 7 | 2017 |
| Recent trends in drug development for the treatment of adenocarcinoma breast cancer: Thiazole, triazole, and thiosemicarbazone analogues as efficient scaffolds CB Scarim, CM Chin Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 6 | 2022 |
| Recent advancement in drug development of nitro(NO2)‐heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosis CB Scarim, FR Pavan Drug Development Research 83 (4), 842-858, 2022 | 6 | 2022 |
| NSAIDs and natural products interactions: Mechanism and clinical implications CB Scarim, VE de Oliveira, JL dos Santos, CM Chin J. Immunol. Clin. Res 4, 1040, 2017 | 5 | 2017 |
| Protective effect of taurine in the induction of genotoxicity by mutagenic drugs PL Bosquesi, CB Scarim, JR Soares de Oliveira, E de Oliveira Vizioli, ... Journal of Pharmacy and Pharmacology, 2021 | 4 | 2021 |
